3.8.0.1 html 265 351 1 false 97 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.amagpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.amagpharma.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.amagpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.amagpharma.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.amagpharma.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.amagpharma.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 2101100 - Disclosure - Description of Business Sheet http://www.amagpharma.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 2102100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 2103100 - Disclosure - Revenue Recognition Sheet http://www.amagpharma.com/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 2104100 - Disclosure - Marketable Securities Sheet http://www.amagpharma.com/role/MarketableSecurities Marketable Securities Notes 10 false false R11.htm 2105100 - Disclosure - Fair Value Measurements Sheet http://www.amagpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 2106100 - Disclosure - Inventories Sheet http://www.amagpharma.com/role/Inventories Inventories Notes 12 false false R13.htm 2107100 - Disclosure - Property, Plant and Equipment, Net Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net Notes 13 false false R14.htm 2108100 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 14 false false R15.htm 2109100 - Disclosure - Current and Long- Term Liabilities Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilities Current and Long- Term Liabilities Notes 15 false false R16.htm 2112100 - Disclosure - Income Taxes Sheet http://www.amagpharma.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2113100 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 17 false false R18.htm 2114100 - Disclosure - Basic and Diluted Net Income (Loss) per Share Sheet http://www.amagpharma.com/role/BasicAndDilutedNetIncomeLossPerShare Basic and Diluted Net Income (Loss) per Share Notes 18 false false R19.htm 2115100 - Disclosure - Equity-Based Compensation Sheet http://www.amagpharma.com/role/EquityBasedCompensation Equity-Based Compensation Notes 19 false false R20.htm 2116100 - Disclosure - Stockholders' Equity Sheet http://www.amagpharma.com/role/StockholdersEquity Stockholders' Equity Notes 20 false false R21.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.amagpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 2118100 - Disclosure - Collaboration, License and Other Strategic Agreements Sheet http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreements Collaboration, License and Other Strategic Agreements Notes 22 false false R23.htm 2119100 - Disclosure - Debt Sheet http://www.amagpharma.com/role/Debt Debt Notes 23 false false R24.htm 2120100 - Disclosure - Recently Issued and Proposed Accounting Pronouncements Sheet http://www.amagpharma.com/role/RecentlyIssuedAndProposedAccountingPronouncements Recently Issued and Proposed Accounting Pronouncements Notes 24 false false R25.htm 2121100 - Disclosure - Recently Adopted Accounting Pronouncements Sheet http://www.amagpharma.com/role/RecentlyAdoptedAccountingPronouncements Recently Adopted Accounting Pronouncements Notes 25 false false R26.htm 2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 26 false false R27.htm 2302302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 27 false false R28.htm 2303301 - Disclosure - Revenue Recognition (Tables) Sheet http://www.amagpharma.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.amagpharma.com/role/RevenueRecognition 28 false false R29.htm 2304301 - Disclosure - Marketable Securities (Tables) Sheet http://www.amagpharma.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.amagpharma.com/role/MarketableSecurities 29 false false R30.htm 2305301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.amagpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.amagpharma.com/role/FairValueMeasurements 30 false false R31.htm 2306301 - Disclosure - Inventories (Tables) Sheet http://www.amagpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.amagpharma.com/role/Inventories 31 false false R32.htm 2307301 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetTables Property, Plant and Equipment, Net (Tables) Tables http://www.amagpharma.com/role/PropertyPlantAndEquipmentNet 32 false false R33.htm 2308301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNet 33 false false R34.htm 2309301 - Disclosure - Current and Long- Term Liabilities (Tables) Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesTables Current and Long- Term Liabilities (Tables) Tables http://www.amagpharma.com/role/CurrentAndLongTermLiabilities 34 false false R35.htm 2312301 - Disclosure - Income Taxes (Tables) Sheet http://www.amagpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.amagpharma.com/role/IncomeTaxes 35 false false R36.htm 2313301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.amagpharma.com/role/AccumulatedOtherComprehensiveLoss 36 false false R37.htm 2314301 - Disclosure - Basic and Diluted Net Income (Loss) per Share (Tables) Sheet http://www.amagpharma.com/role/BasicAndDilutedNetIncomeLossPerShareTables Basic and Diluted Net Income (Loss) per Share (Tables) Tables http://www.amagpharma.com/role/BasicAndDilutedNetIncomeLossPerShare 37 false false R38.htm 2315301 - Disclosure - Equity-Based Compensation (Tables) Sheet http://www.amagpharma.com/role/EquityBasedCompensationTables Equity-Based Compensation (Tables) Tables http://www.amagpharma.com/role/EquityBasedCompensation 38 false false R39.htm 2319301 - Disclosure - Debt (Tables) Sheet http://www.amagpharma.com/role/DebtTables Debt (Tables) Tables http://www.amagpharma.com/role/Debt 39 false false R40.htm 2402403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Restricted Cash (Details) Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRestrictedCashDetails Basis of Presentation and Summary of Significant Accounting Policies - Restricted Cash (Details) Details 40 false false R41.htm 2402404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Concentration and Significant Customer Information (Details) Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesConcentrationAndSignificantCustomerInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Concentration and Significant Customer Information (Details) Details 41 false false R42.htm 2402405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue Recognition Impact of ASC 606 (Details) Sheet http://www.amagpharma.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionImpactOfAsc606Details Basis of Presentation and Summary of Significant Accounting Policies - Revenue Recognition Impact of ASC 606 (Details) Details 42 false false R43.htm 2403402 - Disclosure - Revenue Recognition - Disaggregated Revenue By Major Products and Services (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionDisaggregatedRevenueByMajorProductsAndServicesDetails Revenue Recognition - Disaggregated Revenue By Major Products and Services (Details) Details 43 false false R44.htm 2403403 - Disclosure - Revenue Recognition - Total Gross Product (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionTotalGrossProductDetails Revenue Recognition - Total Gross Product (Details) Details 44 false false R45.htm 2403404 - Disclosure - Revenue Recognition - Product Revenue Allowance and Accrual Activity (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionProductRevenueAllowanceAndAccrualActivityDetails Revenue Recognition - Product Revenue Allowance and Accrual Activity (Details) Details 45 false false R46.htm 2403405 - Disclosure - Revenue Recognition - Receivables, Assets and Liabilities From Contracts With Customers (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionReceivablesAssetsAndLiabilitiesFromContractsWithCustomersDetails Revenue Recognition - Receivables, Assets and Liabilities From Contracts With Customers (Details) Details 46 false false R47.htm 2403406 - Disclosure - Revenue Recognition - Changes in Contract Assets and Liabilities (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionChangesInContractAssetsAndLiabilitiesDetails Revenue Recognition - Changes in Contract Assets and Liabilities (Details) Details 47 false false R48.htm 2403407 - Disclosure - Revenue Recognition - Remaining Performance Obligations (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails Revenue Recognition - Remaining Performance Obligations (Details) Details 48 false false R49.htm 2403408 - Disclosure - Revenue Recognition - Additional Information (Details) Sheet http://www.amagpharma.com/role/RevenueRecognitionAdditionalInformationDetails Revenue Recognition - Additional Information (Details) Details 49 false false R50.htm 2404402 - Disclosure - Marketable Securities (Details) Sheet http://www.amagpharma.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://www.amagpharma.com/role/MarketableSecuritiesTables 50 false false R51.htm 2405402 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 51 false false R52.htm 2405403 - Disclosure - Fair Value Measurements - Contingent Consideration (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsContingentConsiderationDetails Fair Value Measurements - Contingent Consideration (Details) Details 52 false false R53.htm 2405404 - Disclosure - Fair Value Measurements - Debt (Details) Sheet http://www.amagpharma.com/role/FairValueMeasurementsDebtDetails Fair Value Measurements - Debt (Details) Details 53 false false R54.htm 2406402 - Disclosure - Inventories (Details) Sheet http://www.amagpharma.com/role/InventoriesDetails Inventories (Details) Details http://www.amagpharma.com/role/InventoriesTables 54 false false R55.htm 2407402 - Disclosure - Property, Plant and Equipment, Net (Details) Sheet http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetDetails Property, Plant and Equipment, Net (Details) Details http://www.amagpharma.com/role/PropertyPlantAndEquipmentNetTables 55 false false R56.htm 2408402 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetGoodwillDetails Goodwill and Intangible Assets, Net - Goodwill (Details) Details 56 false false R57.htm 2408403 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetScheduleOfIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) Details 57 false false R58.htm 2408404 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Intangible Assets (Details) Details 58 false false R59.htm 2408405 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Expected Future Annual Amortization Expense related to Intangible Assets (Details) Sheet http://www.amagpharma.com/role/GoodwillAndIntangibleAssetsNetScheduleOfExpectedFutureAnnualAmortizationExpenseRelatedToIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Expected Future Annual Amortization Expense related to Intangible Assets (Details) Details 59 false false R60.htm 2409402 - Disclosure - Current and Long- Term Liabilities (Details) Sheet http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesDetails Current and Long- Term Liabilities (Details) Details http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesTables 60 false false R61.htm 2412402 - Disclosure - Income Taxes (Details) Sheet http://www.amagpharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.amagpharma.com/role/IncomeTaxesTables 61 false false R62.htm 2413402 - Disclosure - Accumulated Other Comprehensive Loss (Details) Sheet http://www.amagpharma.com/role/AccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss (Details) Details http://www.amagpharma.com/role/AccumulatedOtherComprehensiveLossTables 62 false false R63.htm 2414402 - Disclosure - Basic and Diluted Net Income (Loss) per Share (Details) Sheet http://www.amagpharma.com/role/BasicAndDilutedNetIncomeLossPerShareDetails Basic and Diluted Net Income (Loss) per Share (Details) Details http://www.amagpharma.com/role/BasicAndDilutedNetIncomeLossPerShareTables 63 false false R64.htm 2415402 - Disclosure - Equity-Based Compensation - Activity Related to Plans (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationActivityRelatedToPlansDetails Equity-Based Compensation - Activity Related to Plans (Details) Details 64 false false R65.htm 2415403 - Disclosure - Equity-Based Compensation - Equity-Based Compensation Expense (Details) Sheet http://www.amagpharma.com/role/EquityBasedCompensationEquityBasedCompensationExpenseDetails Equity-Based Compensation - Equity-Based Compensation Expense (Details) Details 65 false false R66.htm 2416401 - Disclosure - Stockholders' Equity (Details) Sheet http://www.amagpharma.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.amagpharma.com/role/StockholdersEquity 66 false false R67.htm 2417401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.amagpharma.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.amagpharma.com/role/CommitmentsAndContingencies 67 false false R68.htm 2418401 - Disclosure - Collaboration, License and Other Strategic Agreements (Details) Sheet http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreementsDetails Collaboration, License and Other Strategic Agreements (Details) Details http://www.amagpharma.com/role/CollaborationLicenseAndOtherStrategicAgreements 68 false false R69.htm 2419402 - Disclosure - Debt - Schedule of Outstanding Debt Obligations (Details) Sheet http://www.amagpharma.com/role/DebtScheduleOfOutstandingDebtObligationsDetails Debt - Schedule of Outstanding Debt Obligations (Details) Details 69 false false R70.htm 2419403 - Disclosure - Debt - 2023 Senior Notes (Details) Notes http://www.amagpharma.com/role/Debt2023SeniorNotesDetails Debt - 2023 Senior Notes (Details) Details 70 false false R71.htm 2419404 - Disclosure - Debt - Outstanding Convertible Note Balances (Details) Sheet http://www.amagpharma.com/role/DebtOutstandingConvertibleNoteBalancesDetails Debt - Outstanding Convertible Note Balances (Details) Details 71 false false R72.htm 2419405 - Disclosure - Debt - Convertible Notes (Details) Notes http://www.amagpharma.com/role/DebtConvertibleNotesDetails Debt - Convertible Notes (Details) Details 72 false false R73.htm 2419406 - Disclosure - Debt - Total Interest Expense Recognized Related to the Convertible Notes (Details) Notes http://www.amagpharma.com/role/DebtTotalInterestExpenseRecognizedRelatedToConvertibleNotesDetails Debt - Total Interest Expense Recognized Related to the Convertible Notes (Details) Details 73 false false R74.htm 2419407 - Disclosure - Debt - Convertible Bond Hedge, Warrant Transactions (Details) Sheet http://www.amagpharma.com/role/DebtConvertibleBondHedgeWarrantTransactionsDetails Debt - Convertible Bond Hedge, Warrant Transactions (Details) Details 74 false false R75.htm 2419408 - Disclosure - Debt - Future Payments (Details) Sheet http://www.amagpharma.com/role/DebtFuturePaymentsDetails Debt - Future Payments (Details) Details 75 false false All Reports Book All Reports amag-20180331.xml amag-20180331.xsd amag-20180331_cal.xml amag-20180331_def.xml amag-20180331_lab.xml amag-20180331_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true